Ari Ristimäki
University of Helsinki(FI)Helsinki University Hospital(FI)Hospital District of Helsinki and Uusimaa(FI)
Publications by Year
Research Areas
CAR-T cell therapy research, Genetic factors in colorectal cancer, Inflammatory mediators and NSAID effects, Gastric Cancer Management and Outcomes, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016(2017)1,112 cited
- Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.(2002)
- Expression of cyclooxygenase-2 in human lung carcinoma.(1998)
- → Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)(2011)677 cited
- → Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.(1994)659 cited
- → The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling(2009)503 cited
- → Structure of the human cyclo-oxygenase-2 gene(1994)